|
DaVita hires execs for global push - Bizjournals.com |
Bizjournals.com
Kidney dialysis company DaVita Inc. said Monday it's brought in two executives to help the company expand internationally. Kent Thiry, CEO of Denver-based DaVita (NYSE: DVA), said developing the global markets “will play an important role in our
|
|
BAP1 Gene Mutation Raises Mesothelioma And Melanoma Of The Eye Risk - Medical News Today |
Medical News Today
This gene mutation may underlie other types of cancer, including breast, ovarian, pancreatic or renal cancers, they wrote. Mesothelioma is a type of lung cancer that is virtually exclusively caused by exposure to asbestos or erionite - it is typically ...
Fox Chase Doc Uncovers Genetic Link for Mesothelioma Philadelphia Magazine (blog)
Scientists Find Genetic Predisposition to Mesothelioma in Families with Cancer
|
New AAP Urinary Tract Infection Guidelines - About - News Issues |
About - News & Issues
Testing with a renal sonogram and a voiding cystourethogram (VCUG) was routine after diagnose of a UTI in most kids. This helped to detect those kids who had vesicoureteral reflux. Some doctors have switched to doing an acute-phase Tc-99m
|
Senator tours dialysis center, visits patients - Middletown Transcript |
Middletown Transcript
The tour was to learn about kidney disease, its progression to kidney failure and to observe local residents providing and receiving life-saving dialysis treatments. According to the National Kidney Foundation, 31 million people have
|
Eplerenone gains in mild HF cut across high-risk subgroups: EMPHASIS-HF - TheHeart.Org |
TheHeart.Org
Paris, France - Even patients with such high-risk features as diabetes or renal compromise showed highly significant drops in CV mortality or heart-failure hospitalizations from treatment with eplerenone (Inspra, Pfizer) in EMPHASIS-HF,
|
|
|
|
<< Start < Prev 721 722 723 724 725 726 727 728 729 730 Next > End >>
|
Page 730 of 2630 |